TITLE

Study warns of weight pill risks

AUTHOR(S)
Tangley, Laura; Witkin, Gordon
PUB. DATE
July 1997
SOURCE
U.S. News & World Report;07/21/97, Vol. 123 Issue 3, p37
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that physicians have warned that a popular diet pill combination, fenfluramine and phentermine, may cause severe damage to heart valves. Number of prescriptions written for the drugs in 1996; The Food and Drug Administration's warning to physicians.
ACCESSION #
9707176418

 

Related Articles

  • Fen-phen: Risky for dieters in any form.  // Consumer Reports;Sep97, Vol. 62 Issue 9, p6 

    Reports on the dangers of the diet drug fen-phen and its herbal counterpart, Herbal Fen-Phen. Where Herbal Fen-Phen is sold; Why the US Food and Drug Administration recommended against the use of fen-phen; Deaths related to the use of fen-phen.

  • Demise of fen-phen a weighty issue for S.D. dieters. Acello, Richard // San Diego Business Journal;11/10/97, Vol. 18 Issue 45, p13 

    Reports that dieters who have taken `fen-phen,' a two-pill combination of fenfluramine and phentermine, were found to have leaky heart valves. Information on Weight Watchers' `1-2-3 Success' weight loss program; Goal of the program; Other weight loss programs; Key to successful weight loss.

  • Diet pills--out with the old, in with the new.  // Consumers' Research Magazine;Nov97, Vol. 80 Issue 11, p40 

    Introduces the fenfluramine and phentermine diet drugs for weight loss endorsed by Eli Lily and Dupont Merck. Advantages of the drug.

  • Diet drug `fen-phen'  // Ebony;Sep1997, Vol. 52 Issue 11, p21 

    Provides information about the diet-drug combination of fenfluramine and phentermine, commonly known as `fen-pen'. How the drug works; Drug indications; Side effects of the drug; Advice before taking the drug.

  • Every New Mexico drugstore sued over phen-fen. Conlan, Michael F. // Drug Topics;12/7/98, Vol. 142 Issue 23, p24 

    Reports on the state lawsuit against 281 community pharmacies in New Mexico filed at the District Court in Santa Fe in 1998. Allegations of the plaintiffs regarding the manufacturers and sellers of fenfluramine-phentermine; Highlights of the case.

  • Phen-fen frenzy. Clive, Teagan // Joe Weider's Muscle & Fitness;Jan97, Vol. 58 Issue 1, p100 

    Focuses on the phentermine-fenfluramine (phen-fen) drug combination for weight loss. Effectiveness of the combination; Side effects; Disagreement between physicians on the drug combination; Background information on the phen-fen saga; Drug's potential for abuse. INSETS: Who gets phen-fen--and...

  • Health-hazard hype--deflated. Benjamin, Caren // Self;Mar2000, Vol. 22 Issue 3, p80 

    Presents samples of sensationalized health-hazard news in the United States. Side-effects of anti-obesity drugs fenfluramine and phentermine; Health problems caused by Norplant, an implantable contraceptive; Truth about the news on cancer-causing pesticides.

  • Initial weight loss as a predictor of response to obesity drugs. Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L // International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333 

    BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients...

  • Tracking the `fenphen' drug trend.  // Physician & Sportsmedicine;Sep96, Vol. 24 Issue 9, p17 

    Reports on the popularity of the drugs fenfluramine and phentermine for weight reduction and appetite suppression. Mechanism by which both drugs promote weight loss; Prescription dosages of both drugs; Method by which physicians arrive at a decision to five the fenfluramine-phentermine...

  • New research aims to assess Redux/phen-fen controversy. Shaw, Kendall // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP23 

    Reports on the results of a study on the physiological effects of Redux or phentermine-fenfluramine intake. Average duration of Redux therapy; Rates of mild or greater aortic regurgitation; Mitral valve regurgitation; Cardiovascular symptoms; Aortic regurgitation.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics